BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

273 related articles for article (PubMed ID: 15201810)

  • 1. Determination of the calcium oxalate crystallization risk from urine samples: the BONN Risk Index in comparison to other risk formulas.
    Laube N; Hergarten S; Hoppe B; Schmidt M; Hesse A
    J Urol; 2004 Jul; 172(1):355-9. PubMed ID: 15201810
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Why does the Bonn Risk Index discriminate between calcium oxalate stone formers and healthy controls?
    Kavanagh JP; Laube N
    J Urol; 2006 Feb; 175(2):766-70. PubMed ID: 16407047
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Can the Bonn Risk Index be replaced by a simple measurement of the urinary concentration of free calcium ions?
    Laube N; Hergarten S
    J Urol; 2005 Jun; 173(6):2175-7. PubMed ID: 15879882
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Monitoring of the treatment of calcium-oxalate stone formers with the Bonn-Risk-Index].
    Laube N; Schmidt M; Hesse A
    Urologe A; 2003 Feb; 42(2):243-9. PubMed ID: 12607094
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Crystalline aggregation in vitro: interaction between urinary macromolecules and the micromolecular environment.
    Guerra A; Meschi T; Schianchi T; Allegri F; Novarini A; Borghi L
    Acta Biomed; 2002; 73(1-2):11-26. PubMed ID: 12233273
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Relationship between supersaturation and calcium oxalate crystallization in normals and idiopathic calcium oxalate stone formers.
    Borghi L; Guerra A; Meschi T; Briganti A; Schianchi T; Allegri F; Novarini A
    Kidney Int; 1999 Mar; 55(3):1041-50. PubMed ID: 10027942
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A new approach to calculate the risk of calcium oxalate crystallization from unprepared native urine.
    Laube N; Schneider A; Hesse A
    Urol Res; 2000 Aug; 28(4):274-80. PubMed ID: 11011968
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The relation of urinary Tamm-Horsfall-protein on CaOx-crystallization under the scope of the Bonn-Risk-Index.
    Laube N; Glatz S; Hesse A
    Urol Res; 2001 Feb; 29(1):45-9. PubMed ID: 11310215
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Crystallization properties in urine from calcium oxalate stone formers.
    Tiselius HG; Bek-Jensen H; Fornander AM; Nilsson MA
    J Urol; 1995 Sep; 154(3):940-6. PubMed ID: 7637098
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Normative data on the Bonn Risk Index for calcium oxalate crystallization in healthy children.
    Porowski T; Zoch-Zwierz W; Wasilewska A; Spotyk A; Konstantynowicz J
    Pediatr Nephrol; 2007 Apr; 22(4):514-20. PubMed ID: 17216257
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The alteration of urine composition due to stone material present in the urinary tract.
    Laube N; Pullmann M; Hergarten S; Schmidt M; Hesse A
    Eur Urol; 2003 Nov; 44(5):595-9. PubMed ID: 14572760
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Extended metabolic diagnosis of urolithiasis].
    Laube N; Bradenahl J; Thomas E; Meissner A; Müller SC
    Aktuelle Urol; 2006 Nov; 37(6):436-42; quiz 423-4. PubMed ID: 17099832
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Aspects on estimation of the risk of calcium oxalate crystallization in urine.
    Tiselius HG
    Urol Int; 1991; 47(4):255-9. PubMed ID: 1781112
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Citric acid or citrates in urine: which should we focus on in the prevention of calcium oxalate crystals and stones?
    Laube N; Jansen B; Hesse A
    Urol Res; 2002 Oct; 30(5):336-41. PubMed ID: 12389124
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Bonn Risk Index based micromethod for assessing risk of urinary calcium oxalate stone formation.
    Porowski T; Mrozek P; Sidun J; Zoch-Zwierz W; Konstantynowicz J; Kirejczyk JK; Motkowski R; Laube N
    J Urol; 2010 Mar; 183(3):1157-62. PubMed ID: 20096860
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effects of urinary macromolecules on the nucleation of calcium oxalate in idiopathic stone formers and healthy controls.
    Borghi L; Meschi T; Guerra A; Bergamaschi E; Mutti A; Novarini A
    Clin Chim Acta; 1995 Jul; 239(1):1-11. PubMed ID: 7586581
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Testing the predictability of the relative urinary supersaturation from the Bonn-Risk-Index for calcium oxalate stone formation.
    Laube N; Hergarten S; Hesse A
    Clin Chem Lab Med; 2001 Oct; 39(10):966-9. PubMed ID: 11758612
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A new approach to the diagnosis of children's urolithiasis based on the Bonn Risk Index.
    Porowski T; Zoch-Zwierz W; Konstantynowicz J; Taranta-Janusz K
    Pediatr Nephrol; 2008 Jul; 23(7):1123-8. PubMed ID: 18335253
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Analytical precision of the Urolizer for the determination of the BONN-Risk-Index (BRI) for calcium oxalate urolithiasis and evaluation of the influence of 24-h urine storage at moderate temperatures on BRI.
    Berg W; Bechler R; Laube N
    Clin Chem Lab Med; 2009; 47(4):478-82. PubMed ID: 19222375
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The influence of freezer storage of urine samples on the BONN-Risk-Index for calcium oxalate crystallization.
    Laube N; Zimmermann DJ
    Clin Chem Lab Med; 2004; 42(6):665-9. PubMed ID: 15259384
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.